Market Cap : 7.05 B | Enterprise Value : 10.11 B | PE Ratio : 25.57 | PB Ratio : 2.09 |
---|
NAS:SYNH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SYNH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Syneos Health's average Accounts Receivable for the three months ended in Jun. 2022 was $912 Mil. Syneos Health's Revenue for the three months ended in Jun. 2022 was $1,361 Mil. Hence, Syneos Health's Days Sales Outstanding for the three months ended in Jun. 2022 was 61.13.
The historical rank and industry rank for Syneos Health's Days Sales Outstanding or its related term are showing as below:
During the past 11 years, Syneos Health's highest Days Sales Outstanding was 64.57. The lowest was 38.59. And the median was 51.16.
Syneos Health's Days Sales Outstanding increased from Jun. 2021 (52.45) to Jun. 2022 (61.13).
The historical data trend for Syneos Health's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Syneos Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Syneos Health's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Syneos Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as
Days Sales Outstanding (A: Dec. 2021 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2020 ) | + | Accounts Receivable (A: Dec. 2021 )) | / | count ) | / | Revenue (A: Dec. 2021 ) | * | Days in Period |
= | ( (774.605 | + | 873.265) | / | 2 ) | / | 5212.97 | * | 365 |
= | 823.935 | / | 5212.97 | * | 365 | ||||
= | 57.69 |
Syneos Health's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:
Days Sales Outstanding (Q: Jun. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Mar. 2022 ) | + | Accounts Receivable (A: Jun. 2022 )) | / | count ) | / | Revenue (A: Jun. 2022 ) | * | Days in Period |
= | ( (918.248 | + | 904.775) | / | 2 ) | / | 1360.739 | * | 365 / 4 |
= | 911.5115 | / | 1360.739 | * | 365 / 4 | ||||
= | 61.13 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Syneos Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Zulueta Alfonso G | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Bodem Barbara W. | director | C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Brooks Michael Lee | officer: See remarks | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Wilkes David S. | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Connaughton Bernadette | director | C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139 |
Klitgaard William E | director | 210 CARNEGIE CENTER PRINCETON NJ 08540 |
Meyers Kenneth F | director | 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 |
Monaghan Matthew E. | director | ONE INVACARE WAY ELYRIA OH 44035 |
Harty Linda S | director | MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432 |
Kralowetz Donna Hildebrand | officer: SVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Colvin Paul | officer: Pres., Clinical Solutions | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Parks Robert | officer: EVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Olefson Jonathan | officer: General Counsel & Corp Secty | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Meggs Jason M. | officer: Chief Financial Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Gpe Vii Gp S.a.r.l. | 10 percent owner | CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199 |
From GuruFocus
By GuruFocusNews 12-21-2021
By Marketwired 10-06-2021
Other Sources
By Zacks 2022-02-17
By Zacks 2021-10-13
By Zacks 2021-09-16
By Zacks 2022-03-28
By Zacks 2022-02-10
By Zacks 2021-12-03
By Seekingalpha 2022-02-17
By Zacks 2021-11-23
By Zacks 2021-11-03
By Zacks 2022-03-18
By tipranks.com 2022-02-11
By Zacks 2021-09-08
By Zacks 2022-02-18